FDA Approves First Medication for Obstructive Sleep Apnea
Español. Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity, to be …
FDA Approves Zepbound for Obstructive Sleep Apnea - WebMD
Dec. 23, 2024 -- The FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity.
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
Dec 20, 2024 · For people with obstructive sleep apnea, Zepbound should be used with a reduced-calorie diet and increased physical activity, drugmaker Eli Lilly said. The US Food …
FDA approves weight loss drug Zepbound to treat obstructive sleep apnea
Dec 21, 2024 · Shots - Health News ... "This is a major step forward for patients with obstructive sleep apnea," said Dr. Sally Seymour, director of the Division of Pulmonology, Allergy, and …
FDA Approves First Medication for Obstructive Sleep Apnea - PR …
SILVER SPRING, Md., Dec. 20, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe …
FDA approves weight loss drug Zepbound for sleep apnea - NBC News
Dec 20, 2024 · The Food and Drug Administration expanded the approval of weight loss drug Zepbound to treat obstructive sleep apnea in adults with obesity, the drugmaker Eli Lilly said …
F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea
Dec 20, 2024 · The Food and Drug Administration on Friday approved the weight loss drug Zepbound to treat obstructive sleep apnea. It is the first prescription medication approved to …
News Release
INDIANAPOLIS, Dec. 20, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Zepbound ® (tirzepatide) …
FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea
Dec 20, 2024 · The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity.
FDA Approves First Medication for Obstructive Sleep Apnea
SILVER SPRING, Md., Dec. 20, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe …